News tagged with food and drug administration
Related topics: drug , fda , centers for disease control and prevention , heart attack , patients
Coordinated approach needed to protect from arsenic exposure
(HealthDay)—A coordinated approach is necessary for monitoring and regulating the arsenic content of foods, according to a viewpoint piece published online April 29 in JAMA Internal Medicine.
Health
May 02, 2013 |
not rated yet |
0
US Justice Department appeals morning-after case
(AP)—The Obama administration appealed a federal judge's order to lift all age limits on who can buy morning-after birth control pills without a prescription. In appealing the ruling on Wednesday, the administration ...
Medications
May 02, 2013 |
4 / 5 (1) |
0
ER visits tied to ambien on the rise
(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.
Medications
May 01, 2013 |
not rated yet |
0
US: Morning-after pill OK for ages 15 and up (Update)
The U.S. government on Tuesday lowered to 15 the age at which girls can buy the morning-after pill without a prescription and said the emergency contraception no longer has to be kept behind pharmacy counters.
Medications
Apr 30, 2013 |
5 / 5 (1) |
0
Kcentra approved to stop severe bleeding in heart patients
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
Medications
Apr 30, 2013 |
not rated yet |
0
US will investigate added caffeine in foods (Update)
Looking for a new way to get that jolt of caffeine energy? Food companies are betting snacks like potato chips, jelly beans and gum with a caffeinated kick could be just the answer.
Health
Apr 30, 2013 |
not rated yet |
0
Cancer research often falls short: study
Cancer research tends to involve small studies focused on a single therapy, often falling short of scientific standards seen in other medical investigations, said a study released Monday.
Cancer
Apr 29, 2013 |
not rated yet |
0
Cancer studies often lack necessary rigor to answer key questions
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Cancer
Apr 29, 2013 |
5 / 5 (1) |
0
FDA: Purveyors of phony botox targeting U.S. practices
(HealthDay)—Medical practices that purchase Botox may unwittingly be purchasing a fraudulent product not approved by the U.S. Food and Drug Administration for sale in the United States, according to an ...
Medications
Apr 29, 2013 |
not rated yet |
0
FDA announces new network to focus exclusively on patients
(HealthDay)—The U.S. Food and Drug Administration has announced the launch of a new interactive tool for educating patients, their advocates, and consumers about the processes involved in medication development.
Medications
Apr 29, 2013 |
not rated yet |
0
Artificial kidney offers hope to patients tethered to a dialysis machine
No matter what else is happening in his life, David Anderson knows he cannot go far from the dialysis machine that sustains him.
Diseases, Conditions, Syndromes
Apr 29, 2013 |
not rated yet |
0
FDA rejects two HIV drugs from Gilead Sciences
Gilead Sciences Inc. says that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities.
Medications
Apr 29, 2013 |
1 / 5 (1) |
0
Doctors say cancer drug costs are too high
More than 100 doctors from around the world have signed a letter decrying the high cost of cancer drugs which reach $100,000 per year or more, and calling for pharmaceutical companies to ease prices.
Medications
Apr 26, 2013 |
5 / 5 (4) |
2
Research spinoff ReXceptor gets license for Alzheimer's treatment
Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical ...
Alzheimer's disease & dementia
Apr 25, 2013 |
4 / 5 (1) |
0
'Off-the-shelf' artificial blood vessels show promise
(HealthDay)—Artificial blood vessels may one day reduce some complications of dialysis treatment in people with kidney failure, according to the results of early research in animals.
Cardiology
Apr 24, 2013 |
4.8 / 5 (4) |
0
